Treatment of MRSA soft tissue infections: An overview

Injury

Volumn 42, Issue SUPPL. 5, 2011, Pages

  Morgan, M ^a  

^a ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antimicrobials; MRSA; Panton Valentine leucocidin (PVL); Skin and soft tissue infection

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; EXOTOXIN; FUSIDIC ACID; GLYCOPEPTIDE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN; LINEZOLID; MINOCYCLINE; MOXIFLOXACIN; PANTON VALENTINE LEUKOCIDIN; RETAPAMULIN; RIFAMPICIN; TEICOPLANIN;

ABSCESS; BACTERIAL COLONIZATION; BODY FLUID DISCOLORATION; BONE DISCOLORATION; BONE DISEASE; BONE MARROW SUPPRESSION; DISCOLORATION; DISEASE SEVERITY; DRUG EFFICACY; ECZEMA; EMERGENCY WARD; FOLLICULITIS; FULMINATING PURPURA; FURUNCULOSIS; HOSPITAL ADMISSION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NAUSEA; NECROTISING FASCIITIS; NEUROPATHY; NONHUMAN; PHOTOSENSITIVITY; PREVALENCE; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; REVIEW; SIDE EFFECT; SOFT TISSUE INFECTION; STEVENS JOHNSON SYNDROME; SWEAT DISCOLORATION; THROMBOCYTOPENIA; TOOTH DISCOLORATION; TREATMENT PLANNING; VOMITING;

EID: 84555187419     PISSN: 00201383     EISSN: 18790267     Source Type: Journal    
DOI: 10.1016/S0020-1383(11)70127-9     Document Type: Article

References (103)

1. DJ Anderson, DJ Sexton, ZA Kanafani, G Auten, KS Kaye Severe surgical site infections in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus Infect Control Hosp Epidemiol 28 2007 1047 1053 (Pubitemid 47345264)
2. HM Aucken, M Ganner, S Murchan, BD Cookson, AP Johnson A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics J Antimicrob Chemother 50 2002 171 175 (Pubitemid 34918845)
3. GJ Moran, A Krishnadasan, RJ Gorwitz, GE Fosheim, LK McDougal, RB Carey EMERGEncy ID Net Study Group Methicillin resistant S. aureus infections among patients in the emergency department N Engl J Med 355 2006 666 674
4. N Zetola, JS Francis, EL Nuermberger, WR Bishai Community acquired methicillin-resistant Staphylococcus aureus: an emerging threat Lancet Infect Dis 5 2005 275 286 (Pubitemid 40602247)
5. RC Moellering Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection Clin Infect Dis 46 2008 1032 1037
6. RC Moellering The growing menace of community-acquired methicillin-resistant Staphylococcus aureus Ann Intern Med 144 5 2006 368 370
7. JA Rihn, MG Michaels, CD Harner Community acquired methicillin resistant Staphylococcus aureus. An emerging problem in the athletic population Am J Sports Med 33 2005 1924 1929 (Pubitemid 41720596)
8. XW Huijsdens, MG van Santen-Verheuvel, E Spalburg, ME Heck, GN Pluister, BA Eijkelkamp et al. Multiple cases of familial transmission of community-acquired methicillin resistant Staphylococcus aureus J Clin Microbiol 44 2006 2994 2996 (Pubitemid 44228603)
9. LG Miller, F Perdreau-Remington, GL Rieg, S Mehdi, J Perlroth, AS Bayer et al. Necrotizing fasciitis caused by community-associated methicillin- resistant Staphylococcus aureus in Los Angeles N Engl J Med 352 2005 1445 1453 (Pubitemid 40471452)
10. MS Morgan Review: Diagnosis and treatment of Panton-Valentine leukocidin (PVL)-associated staphylococcal pneumonia Int J Antimicrob Agents 30 2007 289 296 (Pubitemid 47361709)
11. JA Al-Tawfiq, RA Aldaabil Community acquired MRSA bacteraemic necrotizing pneumonia in a patient with scrotal ulceration J Infect 51 2005 e241 e243
12. BW Frazee, J Lynn, ED Charlebois, L Lambert, D Lowery, F Perdreau-Remington High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections Ann Emerg Med 45 3 2005 311 320 (Pubitemid 40261163)
13. GY Lina, F Piedmont, M Godail-Gamot, M Bes, MO Peter, V Gauduchon et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia Clin Infect Dis 29 1999 1128 1132 (Pubitemid 30265628)
14. Y Gillet, B Issartel, P Vanhems, JC Fournet, G Lina, M Bes et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients Lancet 359 2002 753 759 (Pubitemid 34215075)
15. GR Kravitz, DJ Dries, ML Peterson, TPM Schlievert Purpura fulminans due to Staphylococcus aureus Clin Infect Dis 40 2005 941 947 (Pubitemid 40418298)
16. PN Panton, FCO Valentine Staphylococcal toxin Lancet i 1932 506 508
17. JK Johnson, T Khoie, S Shurland, K Kreisel, OC Stine, MC Roghmann Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone Emerg Infect Dis 13 2007 1195 1198
18. V Schneider-Lindner, JA Delaney, S Dial, A Dascal, S Suissa Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom Emerg Infect Dis 13 2007 994 999
19. H Grundmann, A Tami, S Hori, M Halwani, R Slack Nottingham Staphylococcus aureus population study: prevalence of MRSA among elderly people in the community BMJ 324 2002 1365 1366 (Pubitemid 34628006)
20. SR Atkinson, J Paul, E Sloan, S Curtis, R Miller The emergence of meticillin-resistant Staphylococcus aureus among injecting drug users J Infect 58 2009 339 345
21. A Holmes, M Ganner, S McGuane, TL Pitt, BD Cookson, AM Kearns Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease J Clin Microbiol 43 5 2005 2384 2390 (Pubitemid 40656255)
22. LJ Shallcross, K Williams, S Hopkins, RW Aldridge, AM Johnson, AC Hayward Panton Valentine leukocidin associated staphylococcal disease: a cross-sectional study at a London hospital, England Clin Microbiol Infect 16 2010 1644 1648
23. RS Daum Clinical practice: skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus N Engl J Med 387 2007 380 390
24. MW Ellis, DR Hospenthal, DP Dooley, PJ Gray, CK Murray Natural history of Community acquired methicillin resistant Staphylococcus aureus colonization and infection in soldiers Clin Infect Dis 39 2004 971 979 (Pubitemid 39313452)
25. LG Miller, F Perdreau-Remington, AS Bayer, B Diep, N Tan, K Bharadwa et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation Clin Infect Dis 44 2007 471 482 (Pubitemid 46233247)
26. EV Barnes, DP Dooley, MJ Hepburn, SE Baum Outcomes of community acquired, methicillin-resistant Staphylococcus aureus, soft tissue infections treated with antibiotics other than vancomycin Mil Med 171 2006 504 507 (Pubitemid 43876696)
27. SM Borchardt, JS Yoder, NS Dworkin Is the recent emergence of community-associated methicillin-resistant Staphylococcus aureus among participants in competitive sports limited to participants? Clin Infect Dis 40 2005 906 907 (Pubitemid 40365519)
28. PR Cohen Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities South Med J 98 2005 596 602 (Pubitemid 40848097)
29. C McCartney, B Cookson, D Dance, C Day, B Duerden, T Elston et al. Interim guidance on diagnosis and management of PVL-associated staphylococcal infections in the UK http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/1218699411960 (downloaded 11 September 2010).
30. DL Stevens, AL Bisno, HF Chambers, ED Everett, P Dellinger, EJ Goldstein Infectious Diseases Society of America Practice guidelines for the diagnosis and management of skin and soft-tissue infections Clin Infect Dis 41 2005 1373 1406 (Pubitemid 41581713)
31. VR Laibl, JS Sheffield, S Roberts, DD McIntire, S Trevino, GD Wendel Jr Clinical presentation of community-associated methicillin resistant Staphylococcus aureus in pregnancy Obstet Gynecol 106 3 2005 461 465 (Pubitemid 41208776)
32. FK Gould, R Brindle, PR Chadwick, AP Fraise, S Hill, D Nathwani MRSA Working Party of the British Society for Antimicrobial Chemotherapy Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom Br J Antimicrob Chemother 63 2009 849 861
33. D Nathwani, M Morgan, RG Masterton, M Dryden, BD Cookson, G French British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA infections Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community J Antimicrob Chemother 61 2008 976 994 (Pubitemid 351545546)
34. AE Simor, L Louie, C Watt, D Gravel, MR Mulvey, J Campbell Canadian Nosocomial Infection Surveillance Program Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008 Antimicrob Agents Chemother 51 2010 2265 2268
35. AM Kearns, M Ganner, RLR Hill, C East, I McCormick Smith, MA Ganner et al. Community-associated MRSA ST8-SCCmecIVa (USA-300): experience in England and Wales Clin Microbiol Infect 13 Suppl 1 2007 S27
36. SK Fridkin, JC Hageman, M Morrison, LT Sanza, K Como-Sabetti, JA Jernigan Active Bacterial Core Surveillance Program of the Emerging Infections Program Network Methicillin-resistant Staphylococcus aureus disease in three communities N Engl J Med 352 2005 1436 1444
37. G Steinkraus, R White, L Friedrich Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), and vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05 J Antimicrob Chemother 60 2007 788 794 (Pubitemid 47434257)
38. LK Hidyat, DI Hsu, R Quist, KA Shriner, A Wong-Beringer High dose vancomycin for methicillin resistant Staphylococcus aureus infections: efficacy and toxicity Arch Intern Med 1566 2006 2138 2144 (Pubitemid 44631403)
39. JF Mohr, IS Murray Vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus Clin Infect Dis 44 2007 1536 1542 (Pubitemid 46871498)
40. PA Moise, G Sakulas, A Forrest, JJ Schentag Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteraemia Antimicrob Agents Chemother 51 2007 2852 2856
41. O Dumitrescu, S Boisset, C Badiou, M Bes, Y Benito, ME Reverdy et al. Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin Antimicrob Agents Chemother 51 2007 1515 1519 (Pubitemid 46586841)
42. DL Stevens, Y Ma, DB Salmi, E McIndoo, RJ Wallace, AE Bryant Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus J Infect Dis 195 2007 202 211 (Pubitemid 46080052)
43. K Bernardo, N Pakulat, S Fleer, A Schnaith, O Utermöhlen, O Krut et al. Sub-inhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression Antimicrob Agents Chemother 48 2004 546 555 (Pubitemid 38141715)
44. SL Kaplan, KG Hulten, BE Gonzalez, WA Hammerman, L Lamberth, J Versalovic et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children Clin Infect Dis 40 2005 1785 1791 (Pubitemid 40799948)
45. JF Marcinak, AL Frank Treatment for community-acquired methicillin-resistant Staphylococcus aureus in children Curr Opin Infect Dis 16 2003 265 269 (Pubitemid 36677323)
46. A Mangili, DR Bica, R Snydman, DH Hamer Daptomycin-resistant methicillin-resistant Staphylococcus aureus bacteraemia Clin Infect Dis 40 2005 1058 1059
47. DJ Skiest Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin J Clin Microbiol 44 2006 655 656 (Pubitemid 43222276)
48. L Cui, E Tominaga, H Neoh, K Hiramatsu Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate susceptibility Staphylococcus aureus Antimicrob Agents Chemother 50 2006 1079 1082 (Pubitemid 43327815)
49. JN Sharpe, TH Shively, HC Polk Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated lower-extremity skin and soft tissue infections caused by methicillin resistant Staphylococcus aureus Am J Surg 189 2005 425 428 (Pubitemid 40488237)
50. AB Pascual, AS Allest, I Garcia, EJ Perea Uptake and intracellular activity of linezolid in human phagocytes and non phagocytic cells Antimicrob Agent Chemother 47 2002 4013 4015 (Pubitemid 35403287)
51. J Weigelt, K Itani, D Stevens, W Lau, M Dryden, C Knirsch, Linezolid CSSTI Study Group Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections Antimicrob Agents Chemother 49 2005 2260 2266 (Pubitemid 40734452)
52. FJ Cloran Cutaneous infections with community-acquired MRSA in aviators Aviat Space Environ Med 77 2006 1271 1274 (Pubitemid 44893779)
53. DJ Elliott, TE Zaoutis, AB Troxel, A Loh, R Keren Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus Pediatrics 123 2009 e959 e966
54. LJ Eron, BA Lipsky, DE Low, D Nathwani, AD Tice, GA Volturo, Expert panel on managing skin and soft tissue infections Managing skin and soft tissue infections: expert panel recommendations on key decision points J Antimicrob Chemother 52 Suppl S1 2003 i3 17
55. LJ Eron Infections of skin and soft tissue: outcomes of a classification scheme Clin Infect Dis 31 2000 287
56. MK Carter, VA Ebers, AK Younes, MK Lacy Doxycycline for community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infection Ann Pharmacother 40 2006 1693 1695 (Pubitemid 44330220)
57. RS Daum, S Kar, P Kirkpatrick Retapamulin Nat Rev Drug Discov 6 2007 865 866 (Pubitemid 350042394)
58. MJ Cenizal, D Skiest, S Luber, R Bedimo, P Davis, P Fox et al. Prospective randomised trial of empiric therapy with trimethoprim- sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 51 2007 2628 2630 (Pubitemid 47047353)
59. J Zander, S Besier, S Faetke, SH Saum, V Müller, TA Wichelhaus Antimicrobial activities of trimethoprim/sulfamethoxazole, 5-iodo-2′- deoxyuridine and rifampicin against Staphylococcus aureus Int J Antimicrob Agents 36 6 2010 562 565
60. K Moumile, C Cadhilac, G Lina, P Berche, C Glorion, A Ferroni Severe osteoarticular infection associated with Panton-Valentine leukocidin-producing Staphylococcus aureus Diagn Microbiol Infect Dis 56 2006 95 97 (Pubitemid 44279943)
61. JJ Ruhe, N Smith, RW Bradsher, A Menon Community onset methicillin-resistant Staphylococcus aureus skin and soft tissue infections: impact of antimicrobial therapy on outcome Clin Infect Dis 44 2007 777 784 (Pubitemid 46365300)
62. A Hankin, W Everett Are antibiotics necessary after incision and drainage of a cutaneous abscess? Ann Emerg Med 50 2007 49 51
63. PS Pannaraj, KG Hulten, BE Gonzalez, EO Mason Jr, SL Kaplan Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection Clin Infect Dis 43 2006 953 960 (Pubitemid 44631092)
64. ME Ruiz, S Yohannes, CG Wladyka Pyomyositis caused by methicillin-resistant Staphylococcus aureus N Engl J Med 352 2005 488 489
65. PM Rajendran, D Young, T Maurer, H Chambers, F Perdreau-Remington, P Ro et al. Randomized double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection Antimicrob Agents Chemother 51 2007 4044 4048 (Pubitemid 350057804)
66. DM Young, HW Harris, ED Charlebois, A Campbell, F Perdreau-Remington, C Lee et al. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients Arch Surg 139 2004 947 951 discussion: 951-3.
67. MC Lee, AM Rios, MF Aten, A Mejias, D Cavuoti, GH McCracken Jr et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus Pediatr Infect Dis J 23 2004 123 127 (Pubitemid 38222783)
68. JJ Ruhe, T Monson, RW Bradsher, A Menon Use of long acting tetracyclines for methicillin-resistant Staphylococcus aureus infection: case series and review of the literature Clin Infect Dis 40 2005 1429 1434 (Pubitemid 40628630)
69. AD Tice, SJ Rehm Meeting the challenges of methicillin-resistant Staphylococcus aureus with outpatient parenteral antimicrobial therapy Clin Infect Dis 51 Suppl 2 2010 S171 S175
70. MS Morgan Management of necrotising fasciitis: a multiparametric approach J Hosp Infect 75 2010 249 257
71. J Darenberg, B Soderquist, BN Normark, A Norrby-Teglund Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications and therapy of toxic shock syndrome Clin Infect Dis 38 2004 836 842 (Pubitemid 38387232)
72. Department of Health Clinical guidelines for the use of intravenous immunoglobulin, 2nd ed http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH-129617 2008 (accessed 12 December 2011).
73. FG Hampson, SW Hancock, RA Primark Disseminated sepsis due to a Panton Valentine leukocidin producing strain of community acquired meticillin resistant Staphylococcus aureus and use of intravenous immunoglobulin therapy Arch Dis Child 91 2006 201 203
74. O Krut, H Sommer, M Kronke Antibiotic induced persistence of cytotoxic Staphylococcus aureus in non phagocytic cells J Antimicrob Chemother 53 2004 167 173 (Pubitemid 38239945)
75. R Romano, D Lu, P Holtom Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among a collegiate football team J Athl Train 41 2006 141 145 (Pubitemid 43807208)
76. BS Schwartz, CJ Graber, BA Diep, L Basuino, F Perdreau-Remington, HF Chambers Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300 Clin Infect Dis 48 2009 1483 1484
77. K Ohlsen, W Ziebuhr, KP Koller, W Hell, TA Wichelhaus, J Hacker Effects of subinhibitory concentration of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates Antimicrob Agent Chemother 42 1998 2817 2823 (Pubitemid 28501209)
78. AL Frank, JF Marcinak, PD Mangat, PC Schreckenberger Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children Pediatr Infect Dis J 18 1999 993 1000
79. LL Han, LK McDougal, RJ Gorwitz, KH Mayer, JB Patel, JM Sennott et al. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 collected at a Boston ambulatory health center J Clin Microbiol 45 2007 1350 1352 (Pubitemid 46626515)
80. JD Szumowski, DE Cohen, F Kanaya, KH Mayer Treatment and outcomes of infections by methicillin resistant Staphylococcus aureus at an ambulatory clinic Antimicrob Chemother 51 2007 423 428 (Pubitemid 46185256)
81. SJ Close, CR McBurney, CG Garvin, DC Chen, SJ Martin Trimethoprim- sulfamethoxazole activity and pharmacodynamics against glycopeptide-intermediate Staphylococcus aureus Pharmacotherapy 22 2002 983 989 (Pubitemid 34831293)
82. SA Grim, RP Rapp, CA Martin, ME Evans Trimethoprim-sulphamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus Pharmacotherapy 25 2005 253 264 (Pubitemid 40223485)
83. N Markowitz, EL Quinn, LD Saravolatz Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection Ann Intern Med 117 1992 190 198
84. AS Kaka, AM Rueda, SA Shelbourne, K Hulten, RJ Hamill, DM Musher Bactericidal activity of orally available agents against methicillin resistant Staphylococcus aureus J Antimicrob Chemother 58 2006 680 683 (Pubitemid 44288140)
85. T Yamaoka The bactericidal effects of anti-MRSA agents with rifampicin and sulfamethoxazole-trimethoprim against intracellular phagocytosed MRSA J Infect Chemother 13 2007 141 146 (Pubitemid 47012505)
86. S Lemaire, K Kosowska-Shick, PC Appelbaum, Y Glupczynski, F Van Bambeke, PM Tulkens Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint J Antimicrob Chemother 66 2011 596 607
87. S Iyer, DH Jones Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak J Am Acad Dermatol 50 2004 854 858 (Pubitemid 38685764)
88. B Shopsin, X Zhao, BN Kreiswirth, GS Tillotson, K Drlica Are the new quinolones appropriate treatment for community-acquired methicillin-resistant Staphylococcus aureus? Int J Antimicrob Agents 24 2004 32 34 (Pubitemid 38844558)
89. RC Owens, KC Lamp, LV Friedrich, R Russo Post marketing clinical experience in patients with skin and soft tissue structure infections treated with daptomycin Am J Med 120 Suppl I 2007 S6 12
90. V Huang, CM Cheung, GM Kaatz, MJ Rybak Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus Int J Antimicrob Agents 35 2010 25 29
91. LM Young, CS Price Community-acquired methicillin-resistant Staphylococcus aureus emerging as an important cause of necrotizing fasciitis Surg Infect 9 2008 469 474
92. FM Abrahamian, DA Talan, GM Moran Management of skin and soft-tissue infections in the emergency department Infect Dis Clin North Am 22 2008 89 116 (Pubitemid 351273541)
93. CA Alvarez, OJ Barientes, AL Leal, GA Contreras, L Barrero, S Rincón et al. Community-associated methicillin-resistant Staphylococcus aureus, Colombia Emerg Infect Dis 12 2006 2000 2001 (Pubitemid 44904954)
94. TC Lee, MM Carrick, BG Scott, JC Hodges, HQ Pham Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital Am J Surg 194 2007 809 812 discussion: 812-3.
95. CH Wong, SH Tan, A Kurup, AB Tan Recurrent necrotizing fasciitis caused by methicillin-resistant Staphylococcus aureus Eur J Clin Microbiol Infect Dis 23 2004 909 911 (Pubitemid 40104747)
96. W Dehority, E Wang, PS Vernon, C Lee, F Perdreau-Remington, J Bradley Community-associated methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a neonate Pediatr Infect Dis J 25 2006 1080 1081 (Pubitemid 44657824)
97. KC Hayani, R Mathew, T Oyedele, KG Hulten Neonatal necrotizing fasciitis due to community-acquired methicillin resistant Staphylococcus aureus Pediatr Infect Dis J 27 5 2008 480 481
98. BA Diep, HF Chambers, CJ Graber, JD Szumowski, LG Miller, LL Han et al. Emergence of multidrug-resistant community associated methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men Ann Intern Med 148 2008 249 257 (Pubitemid 351665484)
99. G Regev-Yochay, E Rubinstein, A Barzilai, Y Carmeli, J Kuint, J Etienne et al. Methicillin-resistant Staphylococcus aureus in neonatal intensive care unit Emerg Infect Dis 11 3 2005 Mar 453 456 (Pubitemid 40315734)
100. CD Salgado, BM Farr, DP Calfee Community acquired methicillin resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors Clin Infect Dis 36 2003 131 139 (Pubitemid 36143409)
101. GJ Noel, RS Strauss, K Amsler, M Heep, R Pypstra, JS Solomkin Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and soft tissue infections caused by Gram-positive bacteria Antimicrob Agents Chemother 52 2008 37 44
102. L Saravolatz, J Pawlak, S Johnson In vitro activity of ceftaroline against community-associated methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, and daptomycin-nonsusceptible Staphylococcus aureus isolates Antimicrob Agents Chemother 54 7 2010 3027 3030
103. E Barton, A MacGowan Future treatment options for Gram-positive infections - looking ahead Clin Microbiol Infect 15 Suppl 6 2009 17 25